247 related articles for article (PubMed ID: 31487723)
1. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan.
Shimamura T; Miyahara K; Takamori A; Hidaka H; Ito Y; Fujimoto S; Takedomi H; Tsuruoka N; Sakata Y; Eguchi Y; Node K; Noda T; Fujimoto K
Digestion; 2020; 101(5):557-562. PubMed ID: 31487723
[TBL] [Abstract][Full Text] [Related]
2. Rectal Diclofenac administration for prevention of post-Endoscopic Retrograde Cholangio-Pancreatography (ERCP) acute pancreatitis. Randomized prospective study.
Geraci G; Palumbo VD; D'Orazio B; Maffongelli A; Fazzotta S; Lo Monte AI
Clin Ter; 2019; 170(5):e332-e336. PubMed ID: 31612188
[TBL] [Abstract][Full Text] [Related]
3. Diclofenac sodium versus ceftazidime for preventing pancreatitis after endoscopic retrograde cholangiopancreatography: a prospective, randomized, controlled trial.
Hauser G; Blažević I; Salkić N; Poropat G; Giljača V; Bulić Z; Štimac D
Surg Endosc; 2017 Feb; 31(2):602-610. PubMed ID: 27317032
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of strategies for preventing post-ERCP pancreatitis after early precut sphincterotomy for biliary access.
Ang TL; Kwek AB; Song M; Li JW; Thurairajah PH
J Dig Dis; 2016 Oct; 17(10):692-696. PubMed ID: 27556283
[TBL] [Abstract][Full Text] [Related]
6. 25 mg versus 50 mg dose of rectal diclofenac for prevention of post-ERCP pancreatitis in Japanese patients: a retrospective study.
Yoshihara T; Horimoto M; Kitamura T; Osugi N; Ikezoe T; Kotani K; Sanada T; Higashi C; Yamaguchi D; Ota M; Mizuno T; Gotoh Y; Okuda Y; Suzuki K
BMJ Open; 2015 Mar; 5(3):e006950. PubMed ID: 25795692
[TBL] [Abstract][Full Text] [Related]
7. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
[TBL] [Abstract][Full Text] [Related]
8. Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement.
Hisa T; Matsumoto R; Takamatsu M; Furutake M
World J Gastroenterol; 2011 Dec; 17(48):5289-94. PubMed ID: 22219598
[TBL] [Abstract][Full Text] [Related]
9. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
Miyatani H; Matsumoto S; Mashima H
J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
[TBL] [Abstract][Full Text] [Related]
10. Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis.
Akshintala VS; Sperna Weiland CJ; Bhullar FA; Kamal A; Kanthasamy K; Kuo A; Tomasetti C; Gurakar M; Drenth JPH; Yadav D; Elmunzer BJ; Reddy DN; Goenka MK; Kochhar R; Kalloo AN; Khashab MA; van Geenen EJM; Singh VK
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):733-742. PubMed ID: 34214449
[TBL] [Abstract][Full Text] [Related]
11. Analysis of risk factors and prevention strategies of post-ERCP pancreatitis.
Lin Y; Liu X; Cao DQ; Tang JH; Wen JJ; Li TF; Liu PF; Xia TS
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5185-5190. PubMed ID: 29228432
[TBL] [Abstract][Full Text] [Related]
12. Combination of diclofenac plus somatostatin in the prevention of post-ERCP pancreatitis: a randomized, double-blind, placebo-controlled trial.
Katsinelos P; Fasoulas K; Paroutoglou G; Chatzimavroudis G; Beltsis A; Terzoudis S; Katsinelos T; Dimou E; Zavos C; Kaltsa A; Kountouras J
Endoscopy; 2012 Jan; 44(1):53-9. PubMed ID: 22198776
[TBL] [Abstract][Full Text] [Related]
13. The Effectiveness of the Rectal Administration of Low-dose Diclofenac for the Prevention of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis.
Okuno M; Shiroko J; Taguchi D; Yamaguchi K; Takada J; Imai S; Sato H; Thanabashi S
Intern Med; 2018 Aug; 57(16):2289-2294. PubMed ID: 29607957
[TBL] [Abstract][Full Text] [Related]
14. Incidence of post-ERCP pancreatitis from direct pancreatic juice collection in hereditary pancreatitis and familial pancreatic cancer before and after the introduction of prophylactic pancreatic stents and rectal diclofenac.
Nicholson JA; Greenhalf W; Jackson R; Cox TF; Butler JV; Hanna T; Harrison S; Grocock CJ; Halloran CM; Howes NR; Raraty MG; Ghaneh P; Johnstone M; Sarkar S; Smart HL; Evans JC; Aithal GP; Sutton R; Neoptolemos JP; Lombard MG
Pancreas; 2015 Mar; 44(2):260-5. PubMed ID: 25438071
[TBL] [Abstract][Full Text] [Related]
15. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
[TBL] [Abstract][Full Text] [Related]
16. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
[TBL] [Abstract][Full Text] [Related]
17. Diclofenac does not reduce the risk of acute pancreatitis in patients with primary sclerosing cholangitis after endoscopic retrograde cholangiography.
Koskensalo V; Tenca A; Udd M; Lindström O; Rainio M; Jokelainen K; Kylänpää L; Färkkilä M
United European Gastroenterol J; 2020 May; 8(4):462-471. PubMed ID: 32213036
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
Troendle DM; Abraham O; Huang R; Barth BA
Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
[TBL] [Abstract][Full Text] [Related]
19. What is impact of nonsteroidal anti-inflammatory drugs in the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a meta-analysis of randomized controlled trials.
Lyu Y; Cheng Y; Wang B; Xu Y; Du W
BMC Gastroenterol; 2018 Jul; 18(1):106. PubMed ID: 29973142
[TBL] [Abstract][Full Text] [Related]
20. Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units.
Rainio M; Lindström O; Udd M; Louhimo J; Kylänpää L
J Gastrointest Surg; 2017 Aug; 21(8):1270-1277. PubMed ID: 28374181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
